A 28-year-old female with folliculitis is not responsive to a 10-day treatment course with penicillin. An enzyme produced by the etiologic agent is most likely responsible for this treatment failure. At which site on the molecule shown does this enzyme act to destroy penicillin?
## **Core Concept**
The question involves a case of treatment failure with penicillin due to resistance mediated by an enzyme produced by the causative agent. This scenario points towards resistance mechanisms involving beta-lactamase enzymes, which are known to confer resistance to penicillins and other beta-lactam antibiotics. Beta-lactamases act by hydrolyzing the beta-lactam ring of these antibiotics, rendering them ineffective.
## **Why the Correct Answer is Right**
The correct answer involves the site on the penicillin molecule where beta-lactamase enzymes act. Beta-lactamases are enzymes produced by certain bacteria that confer resistance to beta-lactam antibiotics, such as penicillins. These enzymes work by cleaving the beta-lactam ring structure of the antibiotic, which is essential for its bactericidal activity. The beta-lactam ring is a critical component for the antibiotic's mechanism of action, which involves inhibiting bacterial cell wall synthesis. Therefore, the action of beta-lactamase at this site (the beta-lactam ring) effectively destroys the antibiotic, leading to treatment failure.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option does not accurately represent the site of action for beta-lactamase enzymes on penicillin. Beta-lactamases specifically target the beta-lactam ring.
- **Option B:** Similar to Option A, this is not the correct site where beta-lactamase acts to destroy penicillin. The correct site is more specific to the beta-lactam ring structure.
- **Option D:** This option is also incorrect because it does not accurately depict the site where beta-lactamase enzymes act to inactivate penicillin.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the production of beta-lactamase is a common mechanism of resistance to penicillins. This resistance can be overcome by using beta-lactamase inhibitors, such as clavulanic acid, which are often combined with penicillins (e.g., amoxicillin-clavulanate) to extend their spectrum of activity against beta-lactamase-producing bacteria.
## **Correct Answer:** .